1.43
price down icon0.69%   -0.01
pre-market  Pre-mercato:  1.38   -0.05   -3.50%
loading

Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
12.55%
24.08
27.54 24.65 26.71 30.82
Depreciation and Amortization
22.22%
2.10
2.70 2.10 2.10 2.10
Operating Income/Loss
12.55%
-24.08
-27.54 -24.65 -26.71 -30.82
Nonoperating Income/Loss
18.55%
0.799
0.674 0.816 1.077 1.392
Income/Loss From Continuing Operations Before Tax
13.33%
-23.28
-26.86 -23.84 -25.63 -29.43
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
13.33%
-23.28
-26.86 -23.84 -25.63 -29.43
Net Income/Loss
13.33%
-23.28
-26.86 -23.84 -25.63 -29.43
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
48.17%
162.79
109.87 0.5317 86.16 85.71
Diluted Average Shares
48.17%
162.79
109.87 0.5317 86.16 85.71
Basic Earnings Per Share
41.67%
-0.14
-0.24 -0.27 -0.30 -0.34
Diluted Earnings Per Share
41.67%
-0.14
-0.24 -0.27 -0.30 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):